Concepedia

Johan Broddefalk

JB

19

Publications

879

Citations

15

H-Index

1994

Active since

Affiliations

AstraZeneca (Sweden)(Current)

Lund University

Umeå University

Uppsala University

Johan Broddefalk is an author at AstraZeneca (Sweden) specializing in biochemistry, medicine, and biomolecular engineering.

Top concepts

Publications per year

1994–2021

19

Publications

19

Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis

Alexandre Corthay, Johan Bäcklund, Johan Broddefalk et al. · European Journal of Immunology · 1998 · 165 citations

, , +18

The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256 – 270 glycopeptide to H-2Aq and H-2Ap molecules

Peter Kjellén, Ulrica Brunsberg, Johan Broddefalk et al. · European Journal of Immunology · 1998 · 90 citations

T Cells Recognize a Glycopeptide Derived from Type II Collagen in a Model for Rheumatoid Arthritis

Johan Broddefalk, Johan Bäcklund, Fredrik Almqvist et al. · Journal of the American Chemical Society · 1998 · 84 citations

, , +23

Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II‐restricted, carbohydrate‐specific T cells

Erik Michaëlsson, Johan Broddefalk, Åke Engström et al. · European Journal of Immunology · 1996 · 75 citations

Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta Cell

Laurent Knerr, Thazha P. Prakash, Richard Lee et al. · Journal of the American Chemical Society · 2021 · 63 citations

Rows per page

1–5 of 19